1. Home
  2. ASRT vs BCOV Comparison

ASRT vs BCOV Comparison

Compare ASRT & BCOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • BCOV
  • Stock Information
  • Founded
  • ASRT 1995
  • BCOV 2004
  • Country
  • ASRT United States
  • BCOV United States
  • Employees
  • ASRT N/A
  • BCOV N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • BCOV EDP Services
  • Sector
  • ASRT Health Care
  • BCOV Technology
  • Exchange
  • ASRT Nasdaq
  • BCOV Nasdaq
  • Market Cap
  • ASRT 113.2M
  • BCOV N/A
  • IPO Year
  • ASRT 1997
  • BCOV 2012
  • Fundamental
  • Price
  • ASRT $1.26
  • BCOV $2.07
  • Analyst Decision
  • ASRT Strong Buy
  • BCOV Buy
  • Analyst Count
  • ASRT 5
  • BCOV 2
  • Target Price
  • ASRT $3.35
  • BCOV $4.00
  • AVG Volume (30 Days)
  • ASRT 625.2K
  • BCOV 175.1K
  • Earning Date
  • ASRT 11-06-2024
  • BCOV 10-30-2024
  • Dividend Yield
  • ASRT N/A
  • BCOV N/A
  • EPS Growth
  • ASRT N/A
  • BCOV N/A
  • EPS
  • ASRT N/A
  • BCOV N/A
  • Revenue
  • ASRT $132,186,000.00
  • BCOV $200,864,000.00
  • Revenue This Year
  • ASRT N/A
  • BCOV N/A
  • Revenue Next Year
  • ASRT $5.50
  • BCOV $2.08
  • P/E Ratio
  • ASRT N/A
  • BCOV N/A
  • Revenue Growth
  • ASRT N/A
  • BCOV N/A
  • 52 Week Low
  • ASRT $0.73
  • BCOV $1.55
  • 52 Week High
  • ASRT $3.27
  • BCOV $3.88
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 51.75
  • BCOV 42.09
  • Support Level
  • ASRT $1.11
  • BCOV $2.05
  • Resistance Level
  • ASRT $1.24
  • BCOV $2.38
  • Average True Range (ATR)
  • ASRT 0.08
  • BCOV 0.13
  • MACD
  • ASRT 0.01
  • BCOV -0.00
  • Stochastic Oscillator
  • ASRT 71.43
  • BCOV 6.06

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: